Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
Clinical Trial Listings
What are Clinical Trials?
Become a Clinical Trial Volunteer
FDA Approved Drugs
Professional Resources
Research Center Profiles
Market Research
Benchmark Reports
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
White Papers
SOPs
Clinical Trial Listings
WCG Clinical
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
»
CenterWatch Staff
Articles by CenterWatch Staff
Here's how to keep patient recruitment momentum high
December 14, 2015
CenterWatch Staff
FDA approves Genentech’s lung cancer treatment
December 14, 2015
CenterWatch Staff
Bristol-Myers Squibb, UCLA enter immuno-oncology collaboration
December 14, 2015
CenterWatch Staff
Veloxis CEO to step down
December 14, 2015
CenterWatch Staff
Xbiotech, NCIC CTG collaborate on phase II NSCLC study
December 14, 2015
CenterWatch Staff
Circuit Therapeutics receives $2.7M DARPA contract
December 14, 2015
CenterWatch Staff
FDA approves emergency treatment for chemotherapy overdoses
December 14, 2015
CenterWatch Staff
AstraZeneca, Wallenberg Center partner on Secretome research
December 14, 2015
CenterWatch Staff
Bracket adds SMS messaging to RTSM platform
December 14, 2015
CenterWatch Staff
LabCorp acquires Pathology Inc assets
December 11, 2015
CenterWatch Staff
Previous
1
2
…
288
289
290
291
292
293
294
295
296
…
1165
1166
Next
Featured Products
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Best Practices for Clinical Trial Site Management
Featured Stories
Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials
Ask the Experts: Applying Quality by Design to Protocols
Clinical Trials Need Greater Representation of Obese Patients, Experts Say
FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here